Articles

RAFARM and BioNanoSim have entered into an agreement to create the company.

A look at how EDOF technology can be categorised into five types

SOE holds a special place in its heart for the up-and-coming young ophthalmologists and is providing them a number of opportunities to hone their skills and establish professional contacts at this meeting.

Novel procedures may hold greater appeal for cataract and refractive surgeons

The European Society of Ophthalmology (SOE) 2023 Congress will convene from June 15 to 17 in Prague, Czech Republic.

Clinical ophthalmology efforts will target the 'busiest' outpatient speciality.

Dr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis

The country is home to 20% of biotechs headquartered in Europe.

Therapeutic has fewer adverse effects in patients with POAG and OHT, study results show

Early detection and diagnosis are key for these young patients

Accessibility obstacles could prevent those with sight loss from receiving support and care.

What ophthalmologists want patients to know ahead of UK bank holiday.

Growing evidence supports dual therapy to slow progression.

The countries join 15 other nations that have eliminated the disease.

Physician supervision stood out as the major determining factor behind ‘excellent’ learning outcomes in a clinical environment.

Identifying pre-myopia creates an opportunity to deploy accessible prevention strategies, which could reduce prevalence of myopia in children.

A research team of scientists from a trio of European universities, led by a Northumbria University academic, has received funding to research age-related macular degeneration.

Horus will increase Iluvien’s commercial presence with Nordic retinal specialists.

In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.

Angela Carneiro, MD, PhD, discusses her position on a discussion titled Presence of Macular Neovascularization on OCTA is Predictive of Subsequent Exudation with David Hutton, Executive Editor, Ophthalmology Times®.

Antonio Campos, MD, PhD, discusses his position on a discussion titled Durability Associated with Multi-target Therapies is Superior to anti-VEGF Mono-target Therapy in AMD with David Hutton, Executive Editor, Ophthalmology Times.®

David S. Boyer, MD, presented data from the PHOTON study examining the safety and efficacy of high-dose aflibercept for treatment of diabetic macular edema at the 2023 Angiogenesis, Exudation, and Degeneration conference.

The Keralink Trial was the first randomized clinical trial that tested the hypothesis that corneal cross-linking (CXL) might decrease keratoconus progression in children compared with the use of spectacles or contact lenses.

Yusuke Oshima, MD, PhD, in a presentation at the 38th Asia-Pacific Academy of Ophthalmology Congress, Kuala Lumpur, Malaysia, discussed the advantages of using a beveled-tip ultra-speed probe for complete vitreous shaving during retinal detachment vitrectomies.

In a presentation at the Asia-Pacific Academy of Ophthalmology Congress in Kuala Lumpur, Malaysia, Kyoko Ohno-Matsui, MD, PhD, noted that changes of scleral curvature and staphyloma edge development may occur in synchronicity.

Arun Singh, MD, discusses Retinoblastoma in 2023 and the advancements of tumor chemotherapy from his presentation at the Asia-Pacific Academy of Ophthalmology (APAO) 2023 conference.

This marks the first, in-person APAO congress since the COVID-19 pandemic

This marks the first, in-person APAO congress since the COVID-19 pandemic

The family-friendly conference, being held at the El Conquistador Resort in Puerto Rico, will promote women in the field, according to founder and program director Bonnie An Henderson, MD.